Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-03T02:03:32.041Z Has data issue: false hasContentIssue false

A Controlled Trial of Anti-Parkinson Drugs in Drug-Induced Parkinsonism

Published online by Cambridge University Press:  29 January 2018

M. Y. Ekdawi
Affiliation:
Netherne Hospital, Coulsdon, Surrey
R. Fowke
Affiliation:
Netherne Hospital, Coulsdon, Surrey

Extract

In his survey of drug-induced extrapyramidal reactions, Ayd (1961) found that they occurred in 38·9 per cent, of 3,775 patients treated with phenothiazines. La Verne (1961) reported the occurrence of dyskinesia in 48 per cent. of 270 cases treated with haloperidol. It is therefore standard practice in many units to administer anti-Parkinson drugs concurrently with tranquillizers.

Type
Research Article
Copyright
Copyright © Royal College of Psychiatrists, 1966 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ayd, F. J. (1961). “A survey of drug-induced extrapyramidal reactions.” J. Amer. med. Ass., 175, 102–8.CrossRefGoogle Scholar
La Verne, A. (1961). “Compendium of neuropsychopharmacology.” J. Neuropsychiat., 2, 280–6.Google Scholar
Onuaguluchi, G. (1963). “Assessment of drug therapy in parkinsonism.” Brit. med. J., 1, 443–8.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.